Category: Adolescents
Increasing availability of high-quality comprehensive data disaggregated by race/ethnicity is a prerequisite for efforts to advance health equity, not only related to COVID-19 but in health and health care more broadly.
Nearly half (48%) of parents of vaccine-eligible children ages 12-17 now say their child has received at least one dose of a COVID-19 vaccine, a new KFF Vaccine Monitor report shows. Another 15% of those parents now say they want to “wait and see” how the vaccine works for others before their adolescent gets it,…More
This report tracks parents’ vaccine COVID-19 vaccine intentions for their children and finds that nearly half of parents of 12-17 year olds say their child has already gotten the COVID-19 vaccine. This report also examines parents’ views on school policies and precautions to limit the spread of COVID-19 and keep children safe.
This report examines the impact of the COVID-19 pandemic on the wellbeing of parents and children. It finds that more than one-third of parents say their child fell behind academically or in their social and emotional development as a result of the pandemic. This report also examines the mental health and wellbeing of parents whose […]
Worries about Long-Term and Serious Side Effects are Parents’ Top Concern; Hispanic and Black Parents Are More Likely than White Parents to Cite Access and Cost Issues As schools around the country prepare to reopen, a majority of parents of school-age children say they do not want their children’s schools to require students to get…More
This report examines attitudes and views of parents as children head back to school amidst the rise in COVID-19 cases due to the delta variant. Nearly half of parents of children ages 12-17, who are currently eligible to receive a COVID-19 vaccine, say their child has already been vaccinated or will get the vaccine right […]
Shots: The CHMP’s positive opinion is based on a P-III study assessing Ultomiris and showed effectiveness in completing C5 complement inhibition @26wks. for children & adolescents aged ≤18yrs. with PNH The study demonstrated that there is no reported treatment-related sAEs, and no patients discontinued treatment during the primary evaluation period or experienced breakthrough hemolysis The […]
In late March 2020, ambulatory visit volumes fell by more than 50% compared to pre-pandemic levels in California, according to a report by the state’s largest nonprofit health information network. Declines in visits were greater among children and adolescents than adults, which is “concerning,” the CEO of the HIN said.
Shots: The approval is based on a P-III study assessing Comirnaty (two 30μg doses) in 2,260 participants aged 12-15yrs. and showed 100% efficacy in participants with/out prior SARS-CoV-2 infection, robust Ab responses and was well tolerated The approval follows CHMP’s positive opinion to authorize the vaccine in this group. The extended indication for the CMA […]
This brief explores factors contributing to poor mental health and substance use outcomes among children during the pandemic, highlighting groups of children who are particularly at risk and barriers to accessing child and adolescent mental health care.
The pandemic has taken a heavy toll on the nation’s mental health, and a new issue brief shows that children are also facing worsening emotional and cognitive health. The brief examines factors contributing to worsening mental health and substance use outcomes among children and adolescents during the pandemic, looking closely at those who are at…More
Shots: The P-II/III TeenCOVE study involves assessing mRNA-1273 (two 100 µg doses) vs PBO in 3700+ participants in a ratio (2:1) aged 12 to <18yrs. in the US The study met its 1EPs i.e non-inferior immunogenicity and demonstrated 93% efficacy in seronegative participants after 14 days following the first dose, was generally well tolerated with […]
Shots: The FDA has expanded the EUA for Pfizer’s COVID-19 vaccine in adolescents based on the data from the P- III trial in 2,260 participants aged 12-15yrs. which showed 100% efficacy and was well-tolerated. The submission of data in children aged 6mos.- 2yrs. are expected in Q4’21 The companies have submitted the data in adolescents […]
This post examines characteristics of adolescents ages 12 to 15 across in the United States to inform COVID-19 vaccination efforts once they become eligible to receive a vaccine.
Throughout the COVID-19 pandemic and resulting economic crisis, about 4 in 10 adults nationwide have reported symptoms of anxiety or depressive disorder – a four-fold increase from pre-pandemic levels. Drawing on the latest national survey data, KFF polling and other research, an updated brief explores what’s known about the pandemic’s impact on people’s mental health…More
This brief examines the implications of coronavirus-related social distancing practices and the current financial crisis on mental health, including challenges to accessing mental health or substance use services.